RESOLUTION_FOR_LONG_ACTING_INJECTABLES_.PDF

Maricopa County — Formal (2023-09-13)

View PDF Item 28 Meeting page

Extracted text (via pymupdf) 2525 characters
RESOLUTION:   
 
Outpatient Sample Program with Alkermes, INC, Otsuka America Pharmaceutical, Inc and Janssen 
Pharmaceuticals, Inc . Long Acting Injectable Antipsychotic Medications 
 
 
WHEREAS, an average of 163 long acting injectable antipsychotic ("LAI") medications are 
administered to patients per month comprising of 60% of the annual pharmacy budget for a jail 
population of approximately 7500; 
 
WHEREAS, recent medical literature indicates that adherence to antipsychotic medication may lead 
to a decrease in criminal recidivism, and where patients are carefully selected, for LAI treatment, in 
combination with discharge planning and "warm handoffs," there is the potential of decreasing the 
recidivism of this vulnerable patient population; 
 
WHEREAS, partnering with pharmaceutical companies to receive LAI medications free-of-charge, 
Maricopa County Correctional Health Services will be able to continue these treatments on stable 
patients and to initiate therapy on candidates who may benefit the most; 
 
NOW THEREFORE: 
 
BE IT RESOLVED,  The Board of Supervisors to hereby adopt Resolution: C Number and authorize 
Maricopa County, through its Department of Correctional Health Services (MCCHS), to complete a non-
financial Certification and Request form for free samples of ARISTADA® from Alkermes, Inc. These samples 
are available in five different strengths: 441 mg, 662 mg, 882 mg, 1064 mg, and Initio 675 mg. Additionally, 
Maricopa County, through its Department of Correctional Health Services (MCCHS), will process a non-
financial Certification and Request form for free samples of Abilify Maintena 400mg and Abilify Asimtufi, 
available in 720 mg and 960 mg, from Otsuka America Pharmaceutical, Inc. Finally, a non-financial 
Certification and Request form will be processed by Maricopa County, through its Department of Correctional 
Health Services (MCDCHS), for free samples of Invega 156 mg, and Invega 234 mg from Janssen 
Pharmaceuticals, Inc. 
 
Dated this _________ day of _________________________, 2023 
 
 
 
 
 
For and Behalf of Maricopa County  
 
 
 
By___________________________ 
    Chairman, Board of Supervisors  
 
___________________________ 
Date 
Attest: 
 
 
 
___________________________ 
Clerk of the Board  
 
___________________________ 
Date  
Approved as to form:                          
 
 
 
___________________________ 
Deputy County Attorney 
 
____________________________ 
Date 
DocuSign Envelope ID: BAF954E3-358A-4AF6-89BB-FA8FAAE86294
8/9/2023